Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 ml) is still effective

[1]  O. Alfieri,et al.  Alcohol septal ablation versus surgical myectomy: a patient with obstructive HCM , 2007, Nature Clinical Practice Cardiovascular Medicine.

[2]  G. Giannakoulas,et al.  Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy , 2007, Heart and Vessels.

[3]  B. Gersh,et al.  Surgery Insight: septal myectomy for obstructive hypertrophic cardiomyopathy—the Mayo Clinic experience , 2007, Nature Clinical Practice Cardiovascular Medicine.

[4]  G. Giannakoulas,et al.  Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: improving cardiac function by generating a myocardial scar. , 2007, European Heart Journal.

[5]  J. Veselka.  Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature. , 2007, Medical science monitor : international medical journal of experimental and clinical research.

[6]  J. Veselka,et al.  Impact of ethanol dosing on the long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a single-center prospective, and randomized study. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[7]  I. Palacios,et al.  Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. , 2006, European Heart Journal.

[8]  Tsung O. Cheng,et al.  Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: How much alcohol should be injected? , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[9]  M. Götte,et al.  Early Onset and Progression of Left Ventricular Remodeling After Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy , 2005, Circulation.

[10]  J. Veselka,et al.  Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes. , 2005, The American journal of cardiology.

[11]  J. Veselka,et al.  Effects of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy on Doppler Tei Index: A Midterm Follow‐Up , 2005, Echocardiography.

[12]  B. Gersh,et al.  The case for surgery in obstructive hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[13]  B. Maron.  Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy , 2000, The Lancet.

[14]  A. Tajik,et al.  Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. , 1996, Circulation.

[15]  U. Sigwart.  Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy , 1995, The Lancet.

[16]  M. Fifer.  Controversies in cardiovascular medicine. Most fully informed patients choose septal ablation over septal myectomy. , 2007, Circulation.

[17]  P. Angelini.  The "1st septal unit" in hypertrophic obstructive cardiomyopathy: a newly recognized anatomo-functional entity, identified during recent alcohol septal ablation experience. , 2007, Texas Heart Institute journal.

[18]  M. Sekiya,et al.  A large conus artery in patients with hypertrophic cardiomyopathy , 2005, Heart and Vessels.

[19]  E. D. Wigle,et al.  Expert consensus document American College of Cardiology / European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy , 2003 .